α-2-macroglobulin in saliva is associated with glycemic control in patients with type 2 diabetes mellitus

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Aitken, Juan Pablo ^a   Ortiz, Carolina ^a   Morales Bozo, Irene ^a   Rojas Alcayaga, Gonzalo ^a   Baeza, Mauricio ^a   Beltran, Caroll ^b   Escobar, Alejandro ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BODY MASS; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCEPTIVE DISCRIMINATION; PRIORITY JOURNAL; SALIVA; SALIVA LEVEL; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED;

AGED; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; SALIVA;

EID: 84925321797     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/128653     Document Type: Article

References (25)

1. F. B. Hu, "Globalization of diabetes: the role of diet, lifestyle, and genes," Diabetes Care, vol. 34, no. 6, pp. 1249-1257, 2011.
2. H. K. Holmer, L. A. Ogden, B. U. Burda, and S. L. Norris, "Quality of clinical practice guidelines for glycemic control in type 2 diabetes mellitus," PLoS ONE, vol. 8, no. 4, Article ID e58625, 2013.
3. C. L. Rohlfing, H.-M. Wiedmeyer, R. R. Little, J. D. England, A. Tennill, and D. E. Goldstein, "Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial," Diabetes Care, vol. 25, no. 2, pp. 275-278, 2002.
4. S. M. Strauss, J. Tuthill, G. Singh et al., "A novel intraoral diabetes screening approach in periodontal patients: results of a pilot study," Journal of Periodontology, vol. 83, no. 6, pp. 699-706, 2012.
5. S. M. Strauss, M. Rosedale, M. A. Pesce et al., "Point-of-care HbA1c testing with the A1cNow test kit in general practice dental clinics: a pilot study involving its accuracy and practical issues in its use," Point of Care, vol. 13, no. 4, pp. 142-147, 2014.
6. C. Llena-Puy, "The role of saliva in maintaining oral health and as an aid to diagnosis," Medicina Oral, Patología oral y Cirugía Bucal, vol. 11, no. 5, pp. E449-E455, 2006.
7. C. A. Schafer, J. J. Schafer, M. Yakob, P. Lima, P. Camargo, and D. T. Wong, "Saliva diagnostics: utilizing oral fluids to determine health status," Monographs in Oral Science, vol. 24, pp. 88-98, 2014.
8. K. James, J. Merriman, R. S. Gray, L. J. Duncan, and R. Herd, "Serumα 2-macroglobulin levels in diabetes," Journal of Clinical Pathology, vol. 33, no. 2, pp. 163-166, 1980.
9. T. Takada, Y. Kodera, M. Matsubara et al., "Serum monomeric alpha2-macroglobulin as a clinical biomarker in diabetes," Atherosclerosis, vol. 228, no. 1, pp. 270-276, 2013.
10. R. S. Gray, K. James, J. Merriman et al., "Alpha 2-macroglobulin and proliferative retinopathy in type 1 diabetes," Hormone and Metabolic Research, vol. 14, no. 8, pp. 389-392, 1982.
11. L. Turecký, V. Kupcová, and M. Szántová, "Alpha 2-macroglobulin in the blood of patients with diabetes mellitus," Bratislavsk é Lekárske Listy, vol. 100, no. 1, pp. 25-27, 1999.
12. P. V. Rao, A. P. Reddy, X. Lu et al., "Proteomic identification of salivary biomarkers of type-2 diabetes," Journal of Proteome Research, vol. 8, no. 1, pp. 239-245, 2009.
13. A. Domján, P. Kakuk, and J. Sándor, "The Helsinki declaration at 50 years: comments on the 2013 modifications," Lege Artis Medicinæ, vol. 24, no. 3, pp. 152-158, 2014.
14. R. Hanas and G. John, "2010 Consensus statement on theworldwide standardization of the hemoglobin A1C measurement," Diabetes Care, vol. 33, no. 8, pp. 1903-1904, 2010.
15. R. R. Little and D. B. Sacks, "HbA1c: how do we measure it and what does itmean?" Current Opinion in Endocrinology, Diabetes and Obesity, vol. 16, no. 2, pp. 113-118, 2009.
16. S. Soman, C. S. Manju, A. A. Rauf, M. Indira, and C. Rajamanickam, "Role of cardiac isoform of alpha-2 macroglobulin in diabeticmyocardium," Molecular and Cellular Biochemistry, vol. 350, no. 1-2, pp. 229-235, 2011.
17. P. A. Wilmarth, M. A. Riviere, D. L. Rustvold, J. D. Lauten, T. E. Madden, and L. L. David, "Two-dimensional liquid chromatography study of the humanwhole saliva proteome," Journal of Proteome Research, vol. 3, no. 5, pp. 1017-1023, 2004.
18. S. Bencharit, S. S. Baxter, J. Carlson et al., "Salivary proteins associated with hyperglycemia in diabetes: a proteomic analysis," Molecular BioSystems, vol. 9, no. 11, pp. 2785-2797, 2013.
19. A. S. Ertugrul, H. Sahin, A. Dikilitas, N. Alpaslan, and A. Bozoglan, "Evaluation of beta-2 microglobulin and alpha-2 macroglobulin levels in patients with different periodontal diseases," Australian Dental Journal, vol. 58, no. 2, pp. 170-175, 2013.
20. A. Bascones-Martínez, M. Muñoz-Corcuera, and J. Bascones-Ilundain, "Diabetes and periodontitis: a bidirectional relationship," Medicina Clínica, 2014.
21. J. Pucher and J. Stewart, "Periodontal disease and diabetes mellitus," Current Diabetes Reports, vol. 4, no. 1, pp. 46-50, 2004.
22. M. B. Border, S. Schwartz, J. Carlson et al., "Exploring salivary proteomes in edentulous patients with type 2 diabetes," Molecular BioSystems, vol. 8, no. 4, pp. 1304-1310, 2012.
23. L. Eliasson and A. Carlén, "An update on minor salivary gland secretions," European Journal of Oral Sciences, vol. 118, no. 5, pp. 435-442, 2010.
24. American Diabetes Association, "Standards of medical care in diabetes-2010," Diabetes Care, vol. 33, supplement 1, pp. S11-S61, 2010.
25. M. T. Rosedale and S. M. Strauss, "Diabetes screening at the periodontal visit: patient and provider experiences with two screening approaches," International Journal of Dental Hygiene, vol. 10, no. 4, pp. 250-258, 2012.